Jun 18, 2025 03:03AM
Apr 16, 2025 04:04PM
Mar 31, 2025 04:37PM
Feb 14, 2025 05:27PM
Jan 31, 2025 05:50AM
Sep 16, 2024 08:00AM
Aug 13, 2024 01:44PM Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine
Aug 8, 2024 12:49AM
Jun 26, 2024 04:25AM
Jun 17, 2024 10:21AM
May 31, 2024 10:33AM
Apr 29, 2024 09:03AM
Feb 23, 2024 01:35AM
Aug 6, 2023 03:54PM Bavarian Nordic Reports Positive Phase 3 Topline Results for Chikungunya Virus Vaccine in Adults and Adolescents
Aug 3, 2023 01:28AM
Jun 20, 2023 02:39AM
Feb 15, 2023 02:00AM
Dec 23, 2022 02:05AM
Dec 22, 2022 06:00AM
Oct 17, 2022 02:46AM
Sep 20, 2022 02:29AM Bavarian Nordic Awarded Ten-Year Contract Amendment valued up to USD 434 million for the Supply of Smallpox and Monkeypox Vaccine to Canada
Aug 24, 2022 04:29AM
Aug 18, 2022 02:24PM
Jul 27, 2022 10:19AM
Jul 27, 2022 10:14AM
Jul 15, 2022 12:56PM
Jul 1, 2022 10:00AM
Jun 10, 2022 05:31AM Bavarian Nordic Receives an Additional Order for JYNNEOS Smallpox and Monkeypox Vaccine from the U.S. Government
Jun 7, 2022 01:28AM
May 30, 2022 02:04PM
May 25, 2022 05:52AM
May 19, 2022 05:46AM
May 18, 2022 01:25AM
May 5, 2022 04:04AM
Apr 20, 2022 01:30AM Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults
Mar 21, 2022 02:26AM
Feb 28, 2022 01:30AM
Feb 14, 2022 02:00AM
Dec 6, 2021 01:37AM
Dec 5, 2021 12:21PM
Sep 1, 2021 02:01AM
Aug 23, 2021 07:45AM Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster Vaccine
Aug 23, 2021 01:00AM
Aug 9, 2021 01:00AM
Jun 11, 2021 01:12PM
Mar 8, 2021 01:00AM
Aug 24, 2020 03:22PM
Jul 22, 2020 02:00AM
Jul 1, 2020 09:23AM Bavarian Nordic Announces European Marketing Authorization for Ebola Vaccine
Jun 12, 2020 01:10PM

324,683 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All